Conclusions: This study showed only 15% of B-CLL cases showing high ZAP-70 expression, a surrogate biomarker for possible aggressive behavior which may necessitate therapeutic intervention and close surveillance. The gene discussed is ZAP70; the disease is B-cell chronic lymphocytic leukemia.